NOI - LC MS Analysis Processed Mouse Serum Samples
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, on behalf of the National Institute on Aging (NIA), has issued a Notice of Intent (NOI) to award a non-competitive, firm fixed-price Purchase Order to Seer, Inc. for LC-MS (liquid chromatography-mass spectrometry) analysis of 280 processed mouse serum samples. This acquisition is for commercial items and is being conducted under FAR 12.603 and 41 U.S.C. 1901, FAR 6.302-3(a)(2)(ii). Responses regarding this NOI are due June 8, 2026, at 9:00 AM EDT.
Scope of Work
The requirement is for high-depth, quantitative proteomic profiles to support ongoing aging research. Key tasks include:
- Performing HPLC mass spectrometry analysis using data-independent acquisition (DIA) mode on a Thermo Scientific Orbitrap Astral Zoom MS instrument.
- Utilizing the proprietary Seer Proteograph Platform and Proteograph Analysis Suite (PAS) for data processing and statistical analysis.
- Providing an electronic copy of spreadsheet or database files with quantitative protein measurements and quality control metrics.
- Providing an electronic copy of a report summarizing laboratory methods and technical specifications.
- Sharing all raw files and data generated with NIA.
Contract & Timeline
- Contract Type: Firm Fixed Price Purchase Order
- Estimated Value: $56,000.00
- Period of Performance: June 8, 2026, to June 7, 2027
- Submission Deadline: June 8, 2026, at 9:00 AM EDT
- Published Date: May 28, 2026
Evaluation
This is a non-competitive acquisition, as Seer, Inc. is identified as the sole provider of the Proteograph workflow, Proteograph Sample Kits, and PAS software. Offerors responding to this NOI must include unit price, list price, shipping/handling, delivery timeframe, F.O.B. point, product descriptions, UEI, TIN, and SAM registration. Evaluation factors for any potential competitive offers may include past performance, technical capability, special features, and expected lifecycle.
Eligibility / Set-Aside
- NAICS Code: 541380 (Testing Laboratories and Services)
- Small Business Size Standard: $22.0 million
- Set-Aside: This requirement is not set aside for small business and is intended for a non-competitive award.
- Offerors must be registered in SAM.gov.
Additional Notes
The government will provide archived serum samples. The National Institute on Aging will have unlimited rights and ownership of all deliverables. Attachments include an Independent Government's Cost Estimate and Evaluation / Selection Criteria.